Intervention for Chronic Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Chronic Disease+1 More
Chronic Disease Risk Reduction - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study tests a web-based chronic disease risk reduction intervention among rural adults.

Eligible Conditions
  • Chronic Disease
  • Risk Reduction

Treatment Effectiveness

Study Objectives

5 Primary · 5 Secondary · Reporting Duration: Baseline, Post-intervention (six weeks from baseline) and 4 weeks post-intervention (10 weeks from baseline).

Week 10
Change in Dietary Fat Intake from Baseline to Post-intervention and 4 weeks post-intervention
Change in Exercise from Baseline to Post-intervention and 4 weeks post-intervention
Change in Health Habits and Knowledge from Baseline to Post-intervention and 4 weeks post-intervention
Change in Physical Activity from Baseline to Post-intervention and 4 weeks post-intervention
Change in Produce and Vegetable Consumption from Baseline to Post-intervention and 4 weeks post-intervention
Change in Sleep from Baseline to Post-intervention and 4 weeks post-intervention
Change in Social Support from Baseline to Post-intervention and 4 weeks post-intervention
Change in Social Support to Eat Better and Move More from Baseline to Post-intervention and 4 weeks post-intervention
Change in Stress from Baseline to Post-intervention and 4 weeks post-intervention
Change in Well-being from Baseline to Post-intervention and 4 weeks post-intervention

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: Chronic Disease Risk Reduction · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post-intervention (six weeks from baseline) and 4 weeks post-intervention (10 weeks from baseline).

Who is running the clinical trial?

Florida State UniversityLead Sponsor
157 Previous Clinical Trials
27,304 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years of age.
You have access to a computer with internet service or smartphone with cellular data.
You have at least one chronic disease risk factor or diagnosis (diabetes, prediabetes, overweight, smoker, hypertension, heart disease, elevated cholesterol level, overweight or obese, etc.).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: October 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.